{
    "2020-04-21": [
        [
            {
                "time": "2023-04-15",
                "original_text": "Q1 Earnings Scorecard and Analyst Reports for Exxon, Oracle & Eli Lilly",
                "features": {
                    "keywords": [
                        "Q1",
                        "Earnings",
                        "Exxon",
                        "Oracle",
                        "Eli Lilly"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "energy",
                        "technology",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-04-16",
                "original_text": "Can Lilly (LLY) Deliver a Beat in Coronavirus-Hit Q1 Earnings?",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Beat",
                        "Coronavirus",
                        "Q1 Earnings"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-04-17",
                "original_text": "Lilly Receives Downgrade to Neutral From Buy at UBS",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Downgrade",
                        "Neutral",
                        "UBS"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-04-18",
                "original_text": "The Zacks Analyst Blog Highlights: Netflix, Silgan, Citrix Systems, Eli Lilly and FirstEnergy",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Analyst",
                        "Netflix",
                        "Silgan",
                        "Citrix Systems",
                        "Eli Lilly",
                        "FirstEnergy"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "entertainment",
                        "industrial",
                        "technology",
                        "healthcare",
                        "utilities"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-04-19",
                "original_text": "Eli Lilly Stock Has Gone as High as It Can Go for Now, Analyst Says",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Stock",
                        "High",
                        "Analyst"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-04-20",
                "original_text": "Buy 5 Top Health Care Stocks Ahead of Q1 Earnings Results",
                "features": {
                    "keywords": [
                        "Buy",
                        "Health Care",
                        "Stocks",
                        "Q1 Earnings"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}